Odyssey shakes hands on $500m-plus deal for Linden's ProPharma Group
Odyssey previously weighed buying ProPharma through existing portfolio company TrialCard, three sources said.
Odyssey previously weighed buying ProPharma through existing portfolio company TrialCard, three sources said.